Publications

  • Elburki, M. S., et al. (2016). "A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects." J Periodontal Res.

  • Zhang, Y., et al. (2016). "A Novel Chemically Modified Curcumin"Normalizes" Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies." Journal of Diabetes Research 2016: 11. 

  • Xu, Y., et al. (2016). "Differential Susceptibility of Human Sp-B Genetic Variants on Lung Injury Caused by Bacterial Pneumonia and the Effect of a Chemically Modified Curcumin." Shock 45(4): 375-384.

  • David Tauber, Basia Galinski, Raquel Castellanos, Joseph Scaduto, Francis Johnson, Lorne Golub, Daniel A. Weiser, "A novel chemically-modified curcumin (CMC 2.24) promotes chemosensitivity in neuroblastoma,' [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; 2016. Abstract nr 2481A

  • Elburki, M. S., C. Rossa, et al. (2014). "A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations." MediatorsInflamm 2014: 10.

  • Antonelli, A. C., Y. Zhang, et al. (2014). "Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives." J Enzyme Inhib Med Chem.

  • Y. Gu, H. Lee, H. Callen, S. Rugova, M. Elburki, Y. Zhang, F. Johnson, and L. Golub, “A Novel Chemically-Modified-Curcumin ‘Normalizes’ Impaired Leukocyte Competence in Diabetic Rats,” J Dent Res 93(Spec Iss A):1025, 2014, (www.iadr.org).

  • Gu, Y., H.-M. Lee, et al. (2013). "4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation." MediatorsInflamm 2013: 10.

  • Botchkina, G. I., E. S. Zuniga, et al. (2013). "Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24."PLoS ONE 8(9): e69884.

  • C. Burchfield, H. Lee, Y. Zhang, F. Johnson, L. Golub, and Y. Gu, “A Novel Chemically-Modified-Curcumin Suppresses Inflammatory Mediators in Diabetic Rat Exudates,” J Dent Res 92(Spec Iss A):1429, 2013, (www.iadr.org).

  • M.S. Elburki, C. Rossa, M. Goodenough, M.R. Guimaraes, H. Lee, F. Johnson, Y. Zhang, and L. Golub, “A Novel Chemically-Modified-Curcumin Improves Experimental Periodontitis in Rats,” J Dent Res 92(Spec Iss A):1428, 2013, (www.iadr.org).

  • H.W. Yu, Y. Zhang, Y. Zhang, H. Lee, S.A. McClain, F. Johnson, and L.M. Golub, “A Novel Chemically-Modified Curcumin (CMC2.24) Improves Diabetic Wound-Healing,” J Dent Res 91(Spec Iss A):1529, 2012, (www.iadr.org).

  • M.S. Elburki, H.M. Lee, N. Gupta, P. Balacky, Y. Zhang, F. Johnson, Y. Zhang, and L.M. Golub, “Chemically-Modified-Curcumins Inhibit Alveolar Bone Loss in Diabetic Rats with Peiodontitis,” J Dent Res 91(Spec Iss A):1528, 2012, (www.iadr.org).

  • N. Napolitano, M. Clemens, H. Lee, Y. Zhang, F. Johnson, L.M. Goulb, and Y. Gu, “Novel Curcumin Derivatives Suppress Inflammatory Mediators in Periodontally-relevant Cells,” J Dent Res 91(Spec Iss A):1527, 2012, (www.iadr.org).

  • M. Clemens, N. Napolitano, Y. Zhang, F. Johnson, H. Lee, L.M. Golub, and Y. Gu, “Chemically Modified Curcumin Normalizes Chronic Inflammation in Diabetic Rats,” J Dent Res 91(Spec Iss A):1526, 2012, (www.iadr.org).

  • Zhang, Y., L. M. Golub, et al. (2012). "pKa, Zinc- and Serum Albumin-Binding of Curcumin and Two Novel Biologically- Active Chemically-Modified Curcumins." Curr Med Chem 19(25): 4367-4375.

  • Zhang, Y., Y. Gu, et al. (2012). "Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins." Curr Med Chem 19(25): 4348-4358.

  • N. Napolitano, D. Kang, M. Clemens, H. Lee, F. Johnson, L. Golub, and Y. Gu, “Chemically Modified Curcumins Suppress Human Mononuclear Cell Cytokines,” J Dent Res 90(Spec Iss A):2292, 2011, (www.iadr.org).

  • M. Elburki, A. Goren, H. Lee, Y. Zhang, N. Gupta, P. Balacky, F. Johnson, L. London, J. Grewal, and L. Golub, “Chemically-Modified Curcumins and Alveolar Bone Loss in Diabetic Rats,” J Dent Res 90(Spec Iss A):2295, 2011, (www.iadr.org).

  • L.M. Goulb, H. Lee, Y. Zhang, L. London, J. Grewal, S. Grewal, Y. Gu, T. Sorsa, T. Tervahartiala, E. Hambardjieva, Y. Zhang, and F. Johnson, “New Collagenase (MMP) Inhibitors for Periodontitis and Other Diseases,” J Dent Res 89(Spec Iss B):1182, 2010, (www.iadr.org).